Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01457404 · ClinicalTrials.gov registry record · Phase 3
Integrated Cognitive Behavioral Therapy (ICBT) for Posttraumatic Stress Disorder (PTSD) and Substance Use Disorders
A Phase 3 study of Substance-Related Disorders and Stress Disorder, Post Traumatic, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 56
- Enrollment target
- 1
- Study location
NCT01457404 is a Phase 3 study of Substance-Related Disorders and Stress Disorder, Post Traumatic that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 56 participants, below the 1,520-participant average among 58 other Substance-Related Disorders trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01457404, a Phase 3 study of Substance-Related Disorders and Stress Disorder, Post Traumatic, has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 56 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to assess the safety and practicality, feasibility and efficacy of ICBT for co-occurring PTSD and substance use disorders within the OEF/OIF/OND Veterans population, as delivered by routine clinicians at the Veterans Affairs.
Conditions Studied
Interventions
- BEHAVIORAL Treatment-as-usual
- BEHAVIORAL Integrated Cognitive Behavioral Therapy
Study Locations (1)
Rhode Island
- Providence Veterans Affairs Medical Center (PVAMC) - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2011-02 |
| Est. Completion | 2015-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01457404
The ClinicalTrials.gov registry entry for NCT01457404 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,520-participant average among 58 other Substance-Related Disorders trials with a reported enrollment target (96% lower). The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Substance-Related Disorders appearing as the primary indexed condition, and to 2 interventions - of which Treatment-as-usual is the first listed.
NCT01457404 reports 1 study location spanning 1 distinct geographic area - top geographies include Rhode Island.
Frequently Asked Questions
What is clinical trial NCT01457404 about?
NCT01457404 is a clinical study titled "Integrated Cognitive Behavioral Therapy (ICBT) for Posttraumatic Stress Disorder (PTSD) and Substance Use Disorders". The purpose of this study is to assess the safety and practicality, feasibility and efficacy of ICBT for co-occurring PTSD and substance use disorders within the OEF/OIF/OND Veterans population, as delivered by routine clinicians at the Veterans Affairs.
What is the current status of trial NCT01457404?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 56 participants. The study started on 2011-02. Estimated completion is 2015-06.
What conditions does trial NCT01457404 study?
This clinical trial studies the following conditions: Substance-Related Disorders, Stress Disorder, Post Traumatic.
What interventions are being tested in trial NCT01457404?
The interventions under investigation include: Treatment-as-usual (BEHAVIORAL), Integrated Cognitive Behavioral Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT01457404?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01457404 being conducted?
This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance-Related Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits
RECRUITING · Phase 3
-
Extended-release Buprenorphine Compared to Sublingual Buprenorphine in Rural Settings (RXR)
ACTIVE NOT RECRUITING · Phase 3
-
Motivational Enhancement Therapy to Improve Treatment Utilization in Pregnant Substance Users - 1
COMPLETED · Phase 3
-
Women's Treatment for Trauma and Substance Use Disorders - 1
COMPLETED · Phase 3
-
Cognitive Behavioral Therapy (CBT) for Posttraumatic Stress Disorder (PTSD) in Community Addiction Treatment
COMPLETED · Phase 3
-
Job-Seekers Training for Patients With Drug Dependence - 1
COMPLETED · Phase 3
Explore more on PlainTrial
Substance-Related Disorders
All registered trials for this condition
Stress Disorder, Post Traumatic
All registered trials for this condition
Rhode Island
All trials with a study site in Rhode Island
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.